Key Details
Price
$7.87Annual ROE
-69.12%Beta
3.00Events Calendar
Next earnings date:
Feb 27, 2025Recent quarterly earnings:
Nov 6, 2024Recent annual earnings:
Feb 27, 2024Next ex-dividend date:
N/ARecent ex-dividend date:
N/ANext split:
N/ARecent split:
N/AAnalyst ratings
Recent major analysts updates
Feb 6, 25 Needham
BuyJan 8, 25 Keybanc
OverweightDec 11, 24 Needham
BuyNov 20, 24 Needham
BuyNov 7, 24 Needham
BuySep 4, 24 Needham
BuySep 3, 24 Leerink Partners
Market PerformSep 3, 24 Jefferies
HoldAug 9, 24 Needham
BuyJul 11, 24 Keybanc
OverweightMarket Data
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Price
Market cap
Technical
Dividend
Recursion Pharmaceuticals doesn't have historical dividend data
Profitability
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Revenue
Profit
EPS
ROA & ROE
EBIT & EBITDA
Valuation
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PE Ratio
PB Ratio
PS Ratio
Enterprise value
EV/EBITDA
Financial Health
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Liquidity
Leverage
Risk & Stability
Balance Sheet
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Assets
Equity
Liabilities
Debt
Expenses
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cash Flow
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Cashflow Activities
Free CashFlow
CAPEX
Institutional Ownership
FAQ
- What is the ticker symbol for Recursion Pharmaceuticals?
- Does Recursion Pharmaceuticals pay dividends?
- What sector is Recursion Pharmaceuticals in?
- What industry is Recursion Pharmaceuticals in?
- What country is Recursion Pharmaceuticals based in?
- When did Recursion Pharmaceuticals go public?
- Is Recursion Pharmaceuticals in the S&P 500?
- Is Recursion Pharmaceuticals in the NASDAQ 100?
- Is Recursion Pharmaceuticals in the Dow Jones?
- When was Recursion Pharmaceuticals's last earnings report?
- When does Recursion Pharmaceuticals report earnings?
- Should I buy Recursion Pharmaceuticals stock now?
What is the ticker symbol for Recursion Pharmaceuticals?
The ticker symbol for Recursion Pharmaceuticals is NASDAQ:RXRX
Does Recursion Pharmaceuticals pay dividends?
No, Recursion Pharmaceuticals does not pay dividends
What sector is Recursion Pharmaceuticals in?
Recursion Pharmaceuticals is in the Healthcare sector
What industry is Recursion Pharmaceuticals in?
Recursion Pharmaceuticals is in the Biotechnology industry
What country is Recursion Pharmaceuticals based in?
Recursion Pharmaceuticals is headquartered in United States
When did Recursion Pharmaceuticals go public?
Recursion Pharmaceuticals's initial public offering (IPO) was on April 16, 2021
Is Recursion Pharmaceuticals in the S&P 500?
No, Recursion Pharmaceuticals is not included in the S&P 500 index
Is Recursion Pharmaceuticals in the NASDAQ 100?
No, Recursion Pharmaceuticals is not included in the NASDAQ 100 index
Is Recursion Pharmaceuticals in the Dow Jones?
No, Recursion Pharmaceuticals is not included in the Dow Jones index
When was Recursion Pharmaceuticals's last earnings report?
Recursion Pharmaceuticals's most recent earnings report was on Nov 6, 2024
When does Recursion Pharmaceuticals report earnings?
The next expected earnings date for Recursion Pharmaceuticals is Feb 27, 2025
Should I buy Recursion Pharmaceuticals stock now?
As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions